Notably, in the vehicle-treated tumors we observed a larger amount of CD8+ T cells at the tumor edge, while in the trametinib-treated group the infiltrated CD8+ T cells also spread inside the tumor bulk (online supplemental figure S4C). The gene discussed is CD8A; the disease is neoplasm.